Novo Nordisk and Roche are two examples of drugmakers that are turning to digital-health startups to better engage with patients and mine valuable real-world evidence.
The Pikachu-catching phenomenon popularized AR and made the technology much more accessible.
AstraZeneca CEO reportedly moving to Teva; the FDA reverses on approval for Amicus drug; Merck names winners of Alexa challenge
Trump administration considers outcomes-based approach to lower drug prices; Sanofi to acquire vaccines biotech; Nestle partners with Enterome to develop microbiome-based diagnostics
Apple reportedly working to bring EMRs to iPhone; FDA to study disclosures in ads; Trump admin discussing drug price EO
Google invests in European biotechs; hospitals that restrict sales-rep visits more likely to prescribe cheaper generics; AI could help doctors with new research
The FDA-approved app will allow MS patients to share their medication injection history with HCPs.
Consent forms and reimbursement are the main deterrents of offering the service.
With physicians spending nearly four hours a day on their electronic health records, experts say voice assistants could help reduce their workload one day.
50% of consumers say they will share their health data with tech giants; pharma CEOs expect pricing proposal from Trump administration; FDA approves generic versions of Strattera
FDA presents ideas to tackle drug prices; patients aware of side effects more likely to report them; scientists use Apple's Research Kit for clinical purposes
Fitness trackers do not reliably track calories, docs find; health-tech startups face market uncertainty; FDA adcom votes in favor of Puma breast-cancer drug
Twitter has launched a customizable Direct Message Card that brands can use to promote and share the bots or other customer experiences they've created, while Snapchat and Instagram have launched stories updates.
The chip-in-a-pill combines antipsychotic Abilify with an ingestible sensor made by Proteus.
Siri and accessibility features take center stage in ads for Global Accessibility Awareness Day.
Robert Califf stepped down from his role as FDA commissioner in January.
FDA requires boxed warning for J&J's Invokana; Amazon to reportedly hire GM to enter pharmacy industry; WannCry ransomware affects some health organizations
To demonstrate the power of goggles equipped with AR and VR, the assistive technology company recreated the event on Facebook Live this weekend.
The artificial pancreas can provide value to the health system.
One executive referred to AI as a "black box" and as the "Tower of Babel."
In his keynote address at the MM&M Transforming Healthcare conference, Dr. Gautam Gulati says the industry is being outpaced by its innovation.
The market for health data and technology is growing, but the industry must also address concerns about privacy, standards, and diversity.
HHS Secretary Tom Price calls for health IT that works for clinicians and better interoperability.
Novartis, Kaiser, and Qualcomm partner on heart-failure pilot; Novartis and GSK disclose DTC plans; cancer-treatment hype can be negative for patients
Healthcare's collision with lower-cost genetic sequencing, mobile tech, AI, and consumerization will transform the trajectory of how we live for the next 10 years.
The device could be used by physicians to better understand the severity of a patient's symptoms and elicit empathy.
The drugmaker saw a gap in patient-physician conversation about retinal disease.
Gilead receives approval to market Harvoni, Sovaldi to adolescents; OncoMed ends mid-stage trials for pancreatic cancer drug; researchers use facial recognition software to diagnose
In the wake of MD Anderson's costly failure with IBM's Watson supercomputer, a Watson backlash brewing in biopharma may lead to a moment of reckoning in life sciences.
MM&M honors 40 upstarts and veteran innovation gurus.